Return On Equity of OptimizeRx Corp from 31 Dec 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
OptimizeRx Corp quarterly and annual Return On Equity in % history and change rate from 31 Dec 2012 to 30 Sep 2025.
  • OptimizeRx Corp Return On Equity for the quarter ending 30 Sep 2025 was 0.03%.
  • OptimizeRx Corp annual Return On Equity for 2024 was -17%, a 16% decline from 2023.
  • OptimizeRx Corp annual Return On Equity for 2023 was -15%, a 68% decline from 2022.
  • OptimizeRx Corp annual Return On Equity for 2022 was -8.7%, a 2994% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

OptimizeRx Corp Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 0.03% +20% 01 Jul 2025 30 Sep 2025
Q2 2025 -8.4% +6.3% +43% 01 Apr 2025 30 Jun 2025
Q1 2025 -13% +1.9% +13% 01 Jan 2025 31 Mar 2025
Q4 2024 -17% -2.4% -16% 01 Oct 2024 31 Dec 2024
Q3 2024 -20% -8.5% -75% 01 Jul 2024 30 Sep 2024
Q2 2024 -15% -3.2% -27% 01 Apr 2024 30 Jun 2024
Q1 2024 -15% -4.2% -39% 01 Jan 2024 31 Mar 2024
Q4 2023 -15% -5.9% -68% 01 Oct 2023 31 Dec 2023
Q3 2023 -11% -3.5% -45% 01 Jul 2023 30 Sep 2023
Q2 2023 -12% -6.3% -120% 01 Apr 2023 30 Jun 2023
Q1 2023 -11% -8.7% -406% 01 Jan 2023 31 Mar 2023
Q4 2022 -8.7% -9% -2994% 01 Oct 2022 31 Dec 2022
Q3 2022 -7.9% -8.9% -850% 01 Jul 2022 30 Sep 2022
Q2 2022 -5.3% -6.2% -673% 01 Apr 2022 30 Jun 2022
Q1 2022 -2.1% -1.2% -119% 01 Jan 2022 31 Mar 2022
Q4 2021 0.3% +5.1% 01 Oct 2021 31 Dec 2021
Q3 2021 1% +13% 01 Jul 2021 30 Sep 2021
Q2 2021 0.92% +17% 01 Apr 2021 30 Jun 2021
Q1 2021 -0.98% +12% +92% 01 Jan 2021 31 Mar 2021
Q4 2020 -4.8% +3.7% +44% 01 Oct 2020 31 Dec 2020
Q3 2020 -12% -8.2% -196% 01 Jul 2020 30 Sep 2020
Q2 2020 -16% -18% -799% 01 Apr 2020 30 Jun 2020
Q1 2020 -12% -15% -624% 01 Jan 2020 31 Mar 2020
Q4 2019 -8.5% -10% -649% 01 Oct 2019 31 Dec 2019
Q3 2019 -4.2% -5% -586% 01 Jul 2019 30 Sep 2019
Q2 2019 2.3% +11% 01 Apr 2019 30 Jun 2019
Q1 2019 2.4% +24% 01 Jan 2019 31 Mar 2019
Q4 2018 1.6% +34% 01 Oct 2018 31 Dec 2018
Q3 2018 0.86% +33% 01 Jul 2018 30 Sep 2018
Q2 2018 -8.8% +16% +65% 01 Apr 2018 30 Jun 2018
Q1 2018 -22% +4.6% +17% 01 Jan 2018 31 Mar 2018
Q4 2017 -33% -14% -72% 01 Oct 2017 31 Dec 2017
Q3 2017 -32% -13% -70% 01 Jul 2017 30 Sep 2017
Q2 2017 -25% -10% -72% 01 Apr 2017 30 Jun 2017
Q1 2017 -27% -16% -151% 01 Jan 2017 31 Mar 2017
Q4 2016 -19% -10% -118% 01 Oct 2016 31 Dec 2016
Q3 2016 -19% -20% -2290% 01 Jul 2016 30 Sep 2016
Q2 2016 -15% -7.5% -105% 01 Apr 2016 30 Jun 2016
Q1 2016 -11% -2.7% -34% 01 Jan 2016 31 Mar 2016
Q4 2015 -8.7% +13% +60% 01 Oct 2015 31 Dec 2015
Q3 2015 0.87% 01 Jul 2015 30 Sep 2015
Q2 2015 -7.1% 01 Apr 2015 30 Jun 2015
Q1 2015 -8% 01 Jan 2015 31 Mar 2015
Q4 2014 -22% 01 Oct 2014 31 Dec 2014

OptimizeRx Corp Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -17% -2.4% -16% 01 Jan 2024 31 Dec 2024
2023 -15% -5.9% -68% 01 Jan 2023 31 Dec 2023
2022 -8.7% -9% -2994% 01 Jan 2022 31 Dec 2022
2021 0.3% +5.1% 01 Jan 2021 31 Dec 2021
2020 -4.8% +3.7% +44% 01 Jan 2020 31 Dec 2020
2019 -8.5% -10% -649% 01 Jan 2019 31 Dec 2019
2018 1.6% +34% 01 Jan 2018 31 Dec 2018
2017 -33% -14% -72% 01 Jan 2017 31 Dec 2017
2016 -19% -10% -118% 01 Jan 2016 31 Dec 2016
2015 -8.7% +13% +60% 01 Jan 2015 31 Dec 2015
2014 -22% -6.3% -41% 01 Jan 2014 31 Dec 2014
2013 -15% +17% +53% 01 Jan 2013 31 Dec 2013
2012 -33% 01 Jan 2012 31 Dec 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.